Biotech Sector Faces Hurdles After an Explosive Year

Biotech Sector Faces Hurdles After an Explosive Year

The biotechnology sector is facing headwinds entering 2022, after an explosive year for funding and initial public offerings. Biotech companies rolled into 2021 with momentum stemming from innovation in the industry and its role in combating the Covid-19 pandemic....
Private Equity Backs Record Volume of Tech Deals

Private Equity Backs Record Volume of Tech Deals

Private-equity firms had a blockbuster year for deal making, largely driven by technology investments. As of mid-December, private-equity firms had announced backing U.S. technology deals totaling $401.71 billion, including new purchases, asset sales and add-on deals,...